The scopolamine-induced mice with impaired cognition were frequently used in AD animal models and clinical trials for investigating efficacy of AChE inhibitors, which scopolamine occupied the muscarinic receptors as an acetylcholine antagonist (McGleenon et al. 1999; Craig et al. 2011; Weinreb et al. 2016). The gene discussed is ACHE; the disease is Alzheimer disease.